Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
November 20, 2018 08:30 ET
|
Zenith Capital Corp.
Collaboration to evaluate ZEN-3694 in combination with Talazoparib in TNBC patients; Phase 1b/2 trial expected to initiate 1Q 2019 CALGARY, Alberta, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Zenith...
Zenith Epigenetics Announces Publication of Covalent Bromodomain Inhibitors, Offering a Novel Approach to Targeting BET Bromodomains
October 01, 2018 08:30 ET
|
Zenith Capital Corp.
CALGARY, Alberta, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a wholly-owned subsidiary of Zenith Capital Corp., announced today the publication of a...
Zenith Announces Voting Results from the 2018 Annual Meeting of Shareholders
September 12, 2018 18:00 ET
|
Zenith Capital Corp.
CALGARY, Alberta, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company") announces that, at its annual meeting of shareholders held earlier today, Zenith shareholders...
Zenith Epigenetics Announces Publication of a Case Study From its Ongoing mCRPC Clinical Study
September 04, 2018 08:00 ET
|
Zenith Capital Corp.
CALGARY, Alberta, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a wholly-owned subsidiary of Zenith Capital Corp., announced today the publication of a...
Zenith Capital Closes $5.7 Million Private Placement
August 31, 2018 18:00 ET
|
Zenith Capital Corp.
This press release is not for dissemination in the United States or through US newswire services CALGARY, Alberta, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company")...
Zenith Announces Further Advancement of Clinical Trial with ZEN-3694, a Proposed Equity Offering and an Update Webcast
June 04, 2018 07:00 ET
|
Zenith Capital Corp.
CALGARY, Alberta, June 04, 2018 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company") today announced that its wholly owned subsidiary, Zenith Epigenetics Ltd. ("Zenith Epigenetics"),...
Zenith Announces Webcast Presentation at the BIO Investor Forum in San Francisco, CA
October 16, 2017 14:17 ET
|
Zenith Capital Corp.
CALGARY, Alberta, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) today announces its participation in the upcoming BIO Investor Forum in San Francisco, CA. Mr....
Zenith Announces Annual General Meeting of Shareholders
October 02, 2017 18:21 ET
|
Zenith Capital Corp.
CALGARY, Alberta, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) announced today that its Annual Meeting of Shareholders (the “Meeting”) is to be held Tuesday,...